返回
Basilea Pharmaceutica AG Allschwil（BPMUF）价格
BPMUF 股价走势图
BPMUF 收益
Basilea Pharmaceutica AG Allschwil
$68.95
0%
$0
收盘价：Jan 20, 16:00:00 GMT-5
$68.95
0%
$0
盘后：Jan 20, 20:00:00 GMT-5
最新收益结果： Q2 '25
报告： 2025-08-19
历史收益
季度性
年度
EPS
收入
Earnings FAQ
BPMUF 最近的每股收益与预期相比如何？
Basilea Pharmaceutica AG Allschwil BPMUF 上一季度的收入表现如何？
Basilea Pharmaceutica AG Allschwil 的收入预期是多少？
Basilea Pharmaceutica AG Allschwil 的盈利质量评分是多少？
Basilea Pharmaceutica AG Allschwil 何时发布财报？
Basilea Pharmaceutica AG Allschwil 的预期收益是多少？
Basilea Pharmaceutica AG Allschwil 是否超出收益预期？
关键数据
前收盘价
$68.95
开盘价
$63.25
当日区间
$63.25 - $68.95
52周范围
$47.5 - $72.14
交易量
200
平均成交量
9
每股收益（TTM）
6.92
股息收益率
--
市值
$846.0M
什么是 BPMUF？
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. The company is headquartered in Allschwil, Basel-Landschaft and currently employs 180 full-time employees. The company went IPO on 2004-03-25. The firm operates in one segment, which is the discovery, development, and commercialization of pharmaceutical products to meet the needs of patients with severe bacterial and fungal infections. The company launched two hospital brands, Cresemba, which is an intravenous and oral drug for the treatment of invasive fungal infections, and Zevtera, which is an intravenous antibiotic for the treatment of severe bacterial infections, especially pneumonia. Additionally, the Company has several preclinical anti-infective assets in their portfolio. Company's products are present in United States, Canada, Europe, Asia, and Africa.